With a balanced risk/reward outlook and a 12-month price target of $277.95, we recommend holding as we monitor Lululemon's ...

He also noted raised outlooks in emerging markets, especially Africa, and described CoreSite as experiencing "exceptional performance" with increased 2025 expectations after the DE1 facility ...

Q2 2025 Management View CEO Zvi Alon stated that Tigo achieved its "sixth increase in sequential quarterly revenue growth, growing 27.7% sequentially and 89.4% on a year-over-year basis." He reported ...

Novo Nordisk's stock has dropped 21% after the company lowered its sales forecast and named Mike Doustdar as the new CEO.

The International Monetary Fund raised its outlook for economic growth across emerging market and developing economies this ...

Schneider adds that investors seem optimistic about American Tower due to stronger domestic organic growth heading into ...

Novo Nordisk lowers 2025 guidance as Wegovy and Ozempic face slower U.S. uptake, competition, and continued compounded GLP-1 ...

Pharma giant Novo Nordisk A/S (NYSE:NVO) is plunging 21% to trade at a nearly three-year low of $54.27, after the company's ...

Novo Nordisk has named Maziar Mike Doustdar, currently the company’s EVP of international operations, as the new CEO.

The International Monetary Fund has revised India’s economic growth forecast upwards to 6.4% for both 2025 and 2026, citing a ...

The International Monetary Fund (IMF) on Tuesday in its latest World Economic Outlook Update projected Pakistan’s GDP growth ...

Company announcement No. 584, 2025 CHIEF EXECUTIVE OFFICER JÖRG BRINKMANN QUOTE "Despite significant improvement efforts over ...